4.2 Article

Genetic and non-genetic factors affecting the visual outcome of ocular Behcet's disease

Journal

HUMAN IMMUNOLOGY
Volume 74, Issue 10, Pages 1363-1367

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2013.06.036

Keywords

-

Categories

Funding

  1. Seoul National University
  2. MEST
  3. NRF [R31-2008-000-10103-0]
  4. MKE/KEIT [10035615]
  5. Korea Evaluation Institute of Industrial Technology (KEIT) [10035615] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Objective: To examine the prognostic factors for visual outcome in Korean BD patients with uveitis. Methods: Seventy-seven Korean BD patients with uveitis were enrolled. HIA-B and HLA-A genotypes were determined by PCR-based method. Visual acuity was measured by Snellen chart. Vision loss was graded into visual impairment (VI) defined as VA < 20/40 for more than 6 months, loss of useful vision (LUV) as VA < 20/200, and near total blindness (NTB) as VA of light perception or worse. Results: VI was associated with a longer duration of uveitis, posterior uveitis, and cataract, LUV with male gender, a longer duration of uveitis, posterior uveitis, and cataract, and NTB with a longer duration of uveitis, cataract, and glaucoma. HLA-B*51 and HLA-A*26:01 did not show any association with VI, LUV, or NTB. However, HLA-B*51 carriers had earlier onset of uveitis and HLA-A*26:01 was strongly associated with posterior uveitis. In patients with posterior uveitis, VI was associated with a longer duration of uveitis and cataract, LUV with a longer duration, and NTB with HLA-B*51. Conclusion: Longer duration of uveitis, posterior uveitis, male gender, cataract, and glaucoma were found to be associated with poor visual outcome in BD-related uveitis. HLA-B*51 was associated with NTB in patients with posterior uveitis. HLA-A*26:01 showed no association with VI, LUV, or NTB, however, was strongly associated with posterior uveitis. (c) 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available